Table 1 Summary of area-level variation for National Health Priority Area cancers and CART analysis results
Type of cancer (ICD-O3 code) | Gender | Tango's MEET | Number of SLAs with high SIR (%) | Sensitivity | Specificity | Variables in final tree1,2 |
|---|---|---|---|---|---|---|
Colorectal cancer | M | 0.693 | NA | NA | NA | NA |
(C18-C20, C218) | F | 0.216 | NA | NA | NA | NA |
Lung (C33-C34) | M | 0.001 | 153 (32%) | 70.1% | 74.9% | SEIFA, ARIA |
| Â | F | 0.001 | 83 (17%) | 51.5% | 82.7% | ARIA, SEIFA |
Melanoma | M | 0.001 | 91 (19%) | 75.0% | 49.8% | ARIA |
(C44 and M872-M879) | F | 0.004 | 54 (11%) | 93.7% | 31.1% | ARIA, SEIFA |
Breast (C50) | F | 0.001 | 79 (17%) | 86.5% | 58.1% | ARIA, SEIFA |
Cervical (C53) | F | 0.023 | 81 (17%) | 79.2% | 79.3% | ARIA, I, SEIFA |
Prostate (C61) | M | 0.001 | 93 (19%) | 70.1% | 58.5% | ARIA, SEIFA |
Non-Hodgkin's lymphoma | M | 0.001 | 57 (12%) | 90.1% | 38.7% | ARIA |
(M959,M967-M971) | F | 0.002 | 57 (12%) | 97.2% | 55.2% | ARIA |